Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey
Background and Objectives: Immune-checitors have been established as a novel standard treatment for non-small cell lung cancer (NSCLC). The aim of this study was to identify factors associated with efficacy and nivolumab-related interstitial pneumonia in NSCLC by evaluating clinical data at the init...
Main Authors: | Hiroki Hata MS, Tadashi Mio PhD, Daisuke Yamashita BS, Chikako Matsumura PhD, Yugo Chisaki PhD, Hideyuki Motohashi PhD, Yoshitaka Yano PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | Cancer Control |
Online Access: | https://doi.org/10.1177/1073274820977200 |
Similar Items
-
Usual interstitial pneumonia progressing to nonspecific interstitial pneumonia-like pattern on high-resolution CT with histologic confirmation
by: Kai Yazaki, MD, et al.
Published: (2021-05-01) -
Smoking history and underlying lung disease are associated with poor outcome in patients developing interstitial pneumonia during low-dose amiodarone therapy
by: Masatsugu Nozoe, MD, PhD, et al.
Published: (2013-02-01) -
Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study
by: Nobukazu Fujimoto, MD, PhD, et al.
Published: (2021-03-01) -
Simultaneous Giant cavity pulmonary lesion and pneumothorax following COVID-19 pneumonia
by: Ramezan Jafari, PhD, et al.
Published: (2021-09-01) -
A Case of Intravascular Diffuse Large B-Cell Lymphoma Initially Suspected as Interstitial Pneumonia Associated With Systemic Scleroderma
by: Tomoyo Oguri MD, PhD, et al.
Published: (2021-03-01)